SOPH Stock Analysis: Buy, Sell, or Hold?
SOPH - SOPHiA GENETICS SA Ordinary Shares
$7.33
0.40 (5.77%)
▲
5d:
+3.82%
30d:
-9.17%
90d:
+21.16%
HOLD
MODERATE Confidence
Analysis Updated: Oct 20, 2026 12:00 AM ET
Earnings: Nov 03, 2026
12d
Get Alerted When SOPH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SOPH shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SOPH shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SOPH is currently trading at $7.33, which is considered oversold relative to its 30-day fair value range of $7.42 to $8.33.
Technical Outlook: Technically, SOPH is in a strong uptrend. Immediate support is located at $6.39, while resistance sits at $7.69. The stock is showing strong short-term momentum, up 5.8% recently.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $9.75 (+40.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SOPH is in a strong uptrend. Immediate support is located at $6.39, while resistance sits at $7.69. The stock is showing strong short-term momentum, up 5.8% recently.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $9.75 (+40.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$7.42 -
$8.33
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (50/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.8%)
- BULLISH: Trading 40.7% below Wall St target ($9.75)
- NEUTRAL: Bottoming setup forming (50/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$7.42 -
$8.33
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$6.39
Resistance Level
$7.69
Current Trend
Strong Uptrend
Technical data as of
Oct 20, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-13.86
Wall Street Target
$9.75
(+40.7%)
Revenue Growth (YoY)
27.2%
Profit Margin
-93.9%
Share & Embed Analysis
Last updated: October 21, 2026 11:10 AM ET
Data refreshes hourly during market hours. Next update: 12:10 PM
Data refreshes hourly during market hours. Next update: 12:10 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SOPH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
29 analysts |
$297 | 33 SELL |
|
BTSG
BrightSpring Health Serv… |
STRONG BUY
18 analysts |
$79 | 51 HOLD |
|
WAY
Waystar Holding Corp. Co… |
STRONG BUY
23 analysts |
$34 | 27 SELL |
|
HQY
HealthEquity Inc |
STRONG BUY
15 analysts |
$119 | 47 HOLD |
|
HNGE
Hinge Health, Inc. |
STRONG BUY
17 analysts |
$112 | 43 HOLD |
